Cell Line Development Market Share

  • Report ID: 713
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Cell Line Development Market Share

APAC Market Statistics

Regionally, the global cell line development market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in Asia Pacific is projected to hold the market share of USD 3,945.1 Million by the end of 2031, up from a revenue of USD 1,166.9 Million in the year 2021. Further, the market in Asia Pacific is expected to grow at the highest CAGR of 13.02% over the forecast period.

North America Market Analysis

Besides North America is set to hold highest industry share of 40% by 2036, backed by increasing investments and funds made available to manufacturing businesses and academic & research institutions to develop cell line-based end products like precision medicine and other treatments. In 2018, the National Institutes of Health's All of Us Research Program funded Genome Centers to generate genotype sequencing data from bio samples. To aid researchers in their quest to better understand how genetics, environment, and lifestyle choices affect health outcomes, they seek to create a varied network of more than 1 million participant partners across the US. In the upcoming years, it is anticipated that these factors will encourage market expansion.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 713
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cell line development is evaluated at USD 5.88 billion.

Cell Line Development Market size was over USD 5.44 billion in 2023 and is poised to cross USD 19 billion by 2036, witnessing more than 10.1% CAGR during the forecast period i.e., between 2024-2036. The market growth is propelled by rising burden of osteoporosis, growing risk of coronavirus, increasing risk of cancer, and others.

North America is set to hold highest industry share of 40% by 2036, backed by increasing investments and funds made available to manufacturing businesses and academic & research institutions to develop cell line-based end products like precision medicine and other treatments.

The major players in the market are Lonza Group Ltd., Thermo Fisher Scientific, Corning Incorporated, General Electric Company, and more.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample